98 related articles for article (PubMed ID: 29683461)
1. Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models.
Goetze RG; Buchholz SM; Patil S; Petzold G; Ellenrieder V; Hessmann E; Neesse A
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29683461
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer.
Goetze RG; Buchholz SM; Ou N; Zhang Q; Patil S; Schirmer M; Singh SK; Ellenrieder V; Hessmann E; Lu QB; Neesse A
Cells; 2019 Jun; 8(6):. PubMed ID: 31181844
[No Abstract] [Full Text] [Related]
4. Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
Fendrich V; Sparn M; Lauth M; Knoop R; Plassmeier L; Bartsch DK; Waldmann J
Pancreatology; 2013; 13(5):502-7. PubMed ID: 24075515
[TBL] [Abstract][Full Text] [Related]
5. A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies.
de Latouliere L; Manni I; Iacobini C; Pugliese G; Grazi GL; Perri P; Cappello P; Novelli F; Menini S; Piaggio G
Ann Anat; 2016 Sep; 207():2-8. PubMed ID: 26704357
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer.
Farr N; Wang YN; D'Andrea S; Starr F; Partanen A; Gravelle KM; McCune JS; Risler LJ; Whang SG; Chang A; Hingorani SR; Lee D; Hwang JH
Int J Hyperthermia; 2018 May; 34(3):284-291. PubMed ID: 28715967
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma.
Hay CA; Sor R; Flowers AJ; Clendenin C; Byrne KT
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31814615
[TBL] [Abstract][Full Text] [Related]
8. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
[TBL] [Abstract][Full Text] [Related]
9. Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound.
Dugnani E; Pasquale V; Marra P; Liberati D; Canu T; Perani L; De Sanctis F; Ugel S; Invernizzi F; Citro A; Venturini M; Doglioni C; Esposito A; Piemonti L
Carcinogenesis; 2018 Sep; 39(9):1197-1206. PubMed ID: 30052815
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer.
Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN
J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879
[TBL] [Abstract][Full Text] [Related]
11. Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic Cancer.
Hasselluhn MC; Klein L; Patzak MS; Buchholz SM; Ströbel P; Ellenrieder V; Maisonneuve P; Neesse A
Cells; 2019 Dec; 9(1):. PubMed ID: 31878349
[TBL] [Abstract][Full Text] [Related]
12. Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan.
Rodriguez Lanzi C; Wei R; Luo D; Mackenzie GG
Neoplasia; 2022 Feb; 24(2):133-144. PubMed ID: 34968866
[TBL] [Abstract][Full Text] [Related]
13. GEMMs as preclinical models for testing pancreatic cancer therapies.
Gopinathan A; Morton JP; Jodrell DI; Sansom OJ
Dis Model Mech; 2015 Oct; 8(10):1185-200. PubMed ID: 26438692
[TBL] [Abstract][Full Text] [Related]
14. A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies.
Majumder K; Arora N; Modi S; Chugh R; Nomura A; Giri B; Dawra R; Ramakrishnan S; Banerjee S; Saluja A; Dudeja V
J Gastrointest Surg; 2016 Jan; 20(1):53-65; discussion 65. PubMed ID: 26582596
[TBL] [Abstract][Full Text] [Related]
15. α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
Verma RK; Yu W; Shrivastava A; Shankar S; Srivastava RK
Sci Rep; 2016 Sep; 6():32743. PubMed ID: 27624879
[TBL] [Abstract][Full Text] [Related]
16. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
17. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
18. Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.
Tseng WW; Winer D; Kenkel JA; Choi O; Shain AH; Pollack JR; French R; Lowy AM; Engleman EG
Clin Cancer Res; 2010 Jul; 16(14):3684-95. PubMed ID: 20534740
[TBL] [Abstract][Full Text] [Related]
19. Modeling the Iatrogenic Pancreatic Cancer Risk After Islet Autotransplantation in Mouse.
Dugnani E; Pasquale V; Liberati D; Citro A; Cantarelli E; Pellegrini S; Marra P; Canu T; Balzano G; Scavini M; Esposito A; Doglioni C; Piemonti L
Am J Transplant; 2017 Oct; 17(10):2720-2727. PubMed ID: 28510280
[TBL] [Abstract][Full Text] [Related]
20. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q
Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
